Seminar: Smaller Drug Companies May Have Niche Role In Neglected Diseases
By Tove Iren S. Gerhardsen There may be a market advantage for small and medium-sized pharmaceutical enterprises (SMEs) in focusing on diseases prevalent in developing countries that are neglected by larger companies, according to a recent seminar. The seminar was…
